NOVARTIS AG holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 10,382,879 | $1,157,483,351 | 0.96% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 9, 2025 |
| June 30, 2025 | 10,401,434 | $1,258,677,530 | 1.00% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 11, 2025 |
| Sept. 30, 2025 | 9,341,854 | $1,197,999,355 | 0.92% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 7,579,274 | $1,044,954,508 | 0.79% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 11, 2026 |
| March 31, 2026 | 7,567,354 | $1,155,913,327 | 0.91% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 11, 2026 |
| June 30, 2026 | 6,592,124 | $1,033,117,672 | 0.61% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 14, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.